MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Terns Pharmaceuticals, Inc. (TERN)

Terns Pharmaceuticals, Inc. (TERN)

|||

Balance Sheets Overview

Current Ratio
6240.90%
Quick Ratio
6240.90%
Cash Ratio
3197.53%
Debt to Asset Ratio
1.81%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2025-12-31
2024-12-31
2023-12-31
2022-12-31
Cash and cash equivalents
524,747
161,439
79,926
143,235
Marketable securities
494,235
196,725
183,514
139,879
Prepaid expenses and other current assets
5,212
3,945
3,992
2,071
Total current assets
1,024,194
362,109
267,432
285,185
Property and equipment, gross
729
2,114
2,115
2,159
Less accumulated depreciation
682
1,892
1,609
1,402
Property and equipment, net
47
222
506
757
Operating lease assets
837
1,248
523
1,047
Other assets
0
350
56
37
Total assets
1,025,078
363,929
268,517
287,026
Accounts payable
1,721
2,148
2,515
1,645
Accrued expenses and other current liabilities
14,216
13,074
8,826
6,162
Current portion of operating lease liabilities
474
428
603
661
Total current liabilities
16,411
15,650
11,944
8,468
Deferred rent, net of current portion
-
-
-
0
Taxes payable, non-current
1,698
1,490
1,206
1,071
Operating lease liabilities, non-current
445
919
0
544
Total liabilities
18,554
18,059
13,150
10,083
Common stock, 0.0001 par value, 150,000,000 shares authorized at december 31, 2025 and 2024 112,324,683 and 87,126,583 shares issued and outstanding at december 31, 2025 and 2024, respectively
11
9
6
5
Additional paid-in capital
1,523,941
767,621
588,008
520,178
Accumulated other comprehensive loss
260
-279
-19
-822
Accumulated deficit
-517,688
-421,481
-332,628
-242,418
Total stockholders' equity
1,006,524
345,870
255,367
276,943
Total liabilities and stockholders' equity
1,025,078
363,929
268,517
287,026
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$524,747K (225.04%↑ Y/Y)Marketable securities$494,235K (151.23%↑ Y/Y)Prepaid expenses andother current assets$5,212K (32.12%↑ Y/Y)Property and equipment,gross$729K (-65.52%↓ Y/Y)Total current assets$1,024,194K (182.84%↑ Y/Y)Operating lease assets$837K (-32.93%↓ Y/Y)Property and equipment,net$47K (-78.83%↓ Y/Y)Less accumulateddepreciation$682K (-63.95%↓ Y/Y)Total assets$1,025,078K (181.67%↑ Y/Y)Total liabilities andstockholders' equity$1,025,078K (181.67%↑ Y/Y)Total stockholders'equity$1,006,524K (191.01%↑ Y/Y)Total liabilities$18,554K (2.74%↑ Y/Y)Accumulated deficit-$517,688K (-22.83%↓ Y/Y)Additional paid-in capital$1,523,941K (98.53%↑ Y/Y)Total currentliabilities$16,411K (4.86%↑ Y/Y)Taxes payable,non-current$1,698K (13.96%↑ Y/Y)Operating leaseliabilities, non-current$445K (-51.58%↓ Y/Y)Accumulated othercomprehensive loss$260K (193.19%↑ Y/Y)Common stock, 0.0001par value,...$11K (22.22%↑ Y/Y)Accrued expenses andother current...$14,216K (8.73%↑ Y/Y)Accounts payable$1,721K (-19.88%↓ Y/Y)Current portion ofoperating lease...$474K (10.75%↑ Y/Y)